pubmed-article:8515439 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0206293 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0040679 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0567416 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0439742 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0596988 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C1444748 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0043309 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C1999230 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
pubmed-article:8515439 | lifeskim:mentions | umls-concept:C1521802 | lld:lifeskim |
pubmed-article:8515439 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:8515439 | pubmed:dateCreated | 1993-7-20 | lld:pubmed |
pubmed-article:8515439 | pubmed:abstractText | Recent X-ray crystallographic and solution X-ray scattering studies have shown that transferrins (serum transferrin, lactoferrin and ovotransferrin) undergo a major conformational change when iron is incorporated into the molecule. Apo-proteins show a structure with open interdomain clefts which close when iron is bound. The closed conformation has been suggested as an important step in the receptor recognition. Here, we report X-ray solution scattering experiments of the mutated N-terminal fragment of human serum transferrin with Asp63-->Ser (Cys). The data provide the first direct experimental evidence for the existence of a trigger mechanism for the closure of the interdomain cleft and that this trigger mechanism is disrupted by mutation of Asp63, the only ligand of iron from domain I. | lld:pubmed |
pubmed-article:8515439 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8515439 | pubmed:language | eng | lld:pubmed |
pubmed-article:8515439 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8515439 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8515439 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8515439 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8515439 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8515439 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8515439 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8515439 | pubmed:month | Jun | lld:pubmed |
pubmed-article:8515439 | pubmed:issn | 0022-2836 | lld:pubmed |
pubmed-article:8515439 | pubmed:author | pubmed-author:WoodworthR... | lld:pubmed |
pubmed-article:8515439 | pubmed:author | pubmed-author:LindleyP FPF | lld:pubmed |
pubmed-article:8515439 | pubmed:author | pubmed-author:HasnainS SSS | lld:pubmed |
pubmed-article:8515439 | pubmed:author | pubmed-author:NelFF | lld:pubmed |
pubmed-article:8515439 | pubmed:author | pubmed-author:MasonA BAB | lld:pubmed |
pubmed-article:8515439 | pubmed:author | pubmed-author:GrossmannJ... | lld:pubmed |
pubmed-article:8515439 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8515439 | pubmed:day | 5 | lld:pubmed |
pubmed-article:8515439 | pubmed:volume | 231 | lld:pubmed |
pubmed-article:8515439 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8515439 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8515439 | pubmed:pagination | 554-8 | lld:pubmed |
pubmed-article:8515439 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:meshHeading | pubmed-meshheading:8515439-... | lld:pubmed |
pubmed-article:8515439 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8515439 | pubmed:articleTitle | Asp ligand provides the trigger for closure of transferrin molecules. Direct evidence from X-ray scattering studies of site-specific mutants of the N-terminal half-molecule of human transferrin. | lld:pubmed |
pubmed-article:8515439 | pubmed:affiliation | Molecular Biophysics Group, SERC Daresbury Laboratory, Warrington, Cheshire, U.K. | lld:pubmed |
pubmed-article:8515439 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8515439 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:8515439 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8515439 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8515439 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8515439 | lld:pubmed |